|
Non-sarcopenic (n = 1270)
|
Sarcopenic (n = 150)
|
p-value
|
---|
CKD-EPI eGFR category
|
No sarcopenia (n = 1114)
|
Probable sarcopenia (n = 156)
|
Confirmed sarcopenia (n = 65)
|
Severe sarcopenia (n = 85)
|
---|
≥90 (n = 42)
|
37 (88.1%)
|
5 (11.9%)
|
0.774
|
29 (69.0%)
|
8 (19.0%)
|
3 (7.1%)
|
2 (4.8%)
| |
60–89 (n = 884)
|
795 (89.9%)
|
89 (10.1%)
|
0.435
|
720 (81.4%)
|
75 (8.5%)
|
46 (5.2%)
|
43 (4.9%)
| |
45–59 (n = 247)
|
226 (91.5%)
|
21 (8.5%)
|
0.246
|
194 (78.5%)
|
32 (13.0%)
|
5 (2.0%)
|
16 (6.5%)
| |
30–44 (n = 163)
|
139 (85.3%)
|
24 (14.7%)
|
0.066
|
112 (68.7%)
|
27 (16.6%)
|
9 (5.5%)
|
15 (9.2%)
| |
15–29 (n = 84)
|
73 (86.9%)
|
11 (13.1%)
|
0.436
|
59 (70.2%)
|
14 (16.7%)
|
2 (2.4%)
|
9 (10.7%)
| |
≥60 (n = 1173)
|
1058 (90.2%)
|
115 (9.8%)
|
0.042
|
943 (80.4%)
|
115 (9.8%)
|
54 (4.6%)
|
61 (5.2%)
|
< 60 (n = 247)
|
212 (85.8%)
|
35 (14.2%)
|
171 (69.2%)
|
41 (16.6%)
|
11 (4.5%)
|
24 (9.7%)
|
- CKD-EPI Chronic Kidney Disease Epidemiological Collaboration, eGFR Estimated glomerular filtration rate